Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562650 · ClinicalTrials.gov registry record · NA
Text Message Treatment for Social Anxiety
A NA study of Social Anxiety, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT03562650 is a NA study of Social Anxiety that has completed, run by Florida State University. The registered enrollment target is 97 participants, below the 600-participant average among 3 other Social Anxiety trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03562650, a NA study of Social Anxiety, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.
Conditions Studied
Interventions
- BEHAVIORAL Safety Behavior Fading
- BEHAVIORAL Present Centered
Study Locations (1)
Florida
- Florida State University, Department of Psychology - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-01-27 |
| Est. Completion | 2019-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03562650
The ClinicalTrials.gov registry entry for NCT03562650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 600-participant average among 3 other Social Anxiety trials with a reported enrollment target (84% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Social Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Safety Behavior Fading is the first listed.
NCT03562650 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03562650 about?
NCT03562650 is a clinical study titled "Text Message Treatment for Social Anxiety". This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.
What is the current status of trial NCT03562650?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2018-01-27. Estimated completion is 2019-03-27.
What conditions does trial NCT03562650 study?
This clinical trial studies the following conditions: Social Anxiety.
What interventions are being tested in trial NCT03562650?
The interventions under investigation include: Safety Behavior Fading (BEHAVIORAL), Present Centered (BEHAVIORAL).
Who is sponsoring clinical trial NCT03562650?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03562650 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.